Home Newsfeeds JP Morgan Maintains Neutral on Foot Locker, Raises Price Target to $46

JP Morgan Maintains Neutral on Foot Locker, Raises Price Target to $46

JP Morgan analyst Matthew Boss maintains Foot Locker (NYSE:FL) with a Neutral and raises the price target from $40 to $46.

byBenzinga Newsdesk

January 26, 2023

1 minute read

JP Morgan analyst Matthew Boss maintains Foot Locker (NYSE:FL) with a Neutral and raises the price target from $40 to $46.

SolarEdge Stock Plunges After The Close: What’s Going On?

By Adam Eckert

August 1, 4:47 PM

SolarEdge Technologies Inc (NASDAQ: SEDG) shares are trading lower in Tuesday's after-hours session on the heels of the company's second-quarter financial results.

SEDG

SunCar Technology Group Inc. Announces $21M Follow-On Offering

By Benzinga Newsdesk

October 26, 9:28 AM

SunCar Technology Group Inc. (the "Company" or "SunCar") (NASDAQ:SDA), a leading provider of digitalized enterprise automotive after-sales services and online auto insurance intermediation services in China, today

SDA

Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton’s Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations And Neuroinflammation In Models Of Alzheimer’s Disease

By Benzinga Newsdesk

November 15, 9:18 AM

Athira Pharma, Inc. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, presented new preclinical data supporting

ATHA

Troubled Crypto Exchange FTX Reopens Withdrawals

By Vandana Singh

November 10, 1:01 PM

The price of Bitcoin, along with other digital coins, fell after the world's biggest cryptocurrency exchange, Binance, pulled out of a deal to buy FTX (CRYPTO: FTT/USD), citing due diligence concerns. It has left some FTX customers unable to withdraw from the exchange, which is used to buy and sell various digital tokens.

$BNB

JP Morgan Maintains Neutral on Foot Locker, Raises Price Target to $46

Related Posts

SolarEdge Stock Plunges After The Close: What’s Going On?

SunCar Technology Group Inc. Announces $21M Follow-On Offering

Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton’s Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations And Neuroinflammation In Models Of Alzheimer’s Disease

Troubled Crypto Exchange FTX Reopens Withdrawals